New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
16:38 EDTBSXBoston Scientific receives FDA approval for REBEL Platinum Stent system
Boston Scientific has received FDA approval for the REBEL Platinum Chromium Coronary Stent System, the company's latest generation bare-metal stent for the treatment of coronary artery disease. Bare-metal stents continue to play an important role in the treatment of CAD and represent a significant portion of the global stent market. The company announced CE Mark for the Rebel Stent System in February. The REBEL Stent System expands the Boston Scientific family of stents featuring its proprietary platinum chromium alloy and a customized stent architecture design. The REBEL Stent offers the identical stent platform as the Promus PREMIER Drug-Eluting Stent but without the Everolimus drug.
News For BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2016
07:34 EDTBSXBoston Scientific 2016 results poised to beat expectations, says RBC Capital
Subscribe for More Information
06:36 EDTBSXBoston Scientific post-earnings selloff overdone, says Leerink
Subscribe for More Information
February 4, 2016
14:53 EDTBSXBoston Scientific weakness a buying opportunity, says BofA/Merrill
11:21 EDTBSXOptions with increasing call volume; FMC HST XME RIO BHP PAY DNDK BSX ALLY SWFT
10:20 EDTBSXHigh option volume stocks: EPC DK DNKN TTWO AVT VHC RL ZBH BSX AGCO
Subscribe for More Information
06:42 EDTBSXBoston Scientific reports Q4 adjusted EPS 26c, consensus 25c
Reports Q4 revenue $1.98B, consensus $1.99B.
February 3, 2016
14:48 EDTBSXNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Philip Morris (PM), consensus 81c... AstraZeneca (AZN), consensus 88c... Occidental Petroleum (OXY), consensus (12c)... ConocoPhillips (COP), consensus (65c)... Cigna (CI), consensus $1.80... Intercontinental Exchange (ICE), consensus $3.01... Boston Scientific (BSX), consensus 25c... Charter Communications (CHTR), consensus (12c)... Ralph Lauren (RL), consensus $2.13... Dunkin' Brands (DNKN), consensus 50c... GrubHub (GRUB), consensus 14c... Level 3 (LVLT), consensus 53c... AmerisourceBergen (ABC), consensus $1.25... Cummins (CMI), consensus $2.11.
January 28, 2016
07:14 EDTBSXBoston Scientific and Accenture develop digital health solution
Subscribe for More Information
January 25, 2016
17:16 EDTBSXMMS exploring sale of acute care unit, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use